Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Insights into Imaging
Published in: Insights into Imaging 5-6/2010

Open Access 01-11-2010 | Review

Uncharted waters: rare and unclassified cardiomyopathies characterized on cardiac magnetic resonance imaging

Authors: Ailbhe C. O’Neill, Shaunagh McDermott, Carole A. Ridge, Kenneth McDonald, David Keane, Jonathan D. Dodd

Published in: Insights into Imaging | Issue 5-6/2010

Login to get access

Abstract

Cardiac magnetic resonance imaging (CMR) has undergone considerable technology advances in recent years, so that it is now entering into mainstream cardiac imaging practice. In particular, CMR is proving to be a valuable imaging tool in the detection, morphological assessment and functional assessment of cardiomyopathies. Although our understanding of this broad group of heart disorders continues to expand, it is an evolving group of entities, with the rarer cardiomyopathies remaining poorly understood or even unclassified. In this review, we describe the clinical and pathophysiological aspects of several of the rare/unclassified cardiomyopathies and their appearance on CMR.
Literature
1.
Rosamond W et al (2007) Heart disease and stroke statistics—2007 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 115(5):e69–e171PubMedCrossRef
2.
Quinones MA et al (2003) American College of Cardiology/American Heart Association clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on clinical competenc. Circulation 107(7):1068–1089PubMedCrossRef
3.
Bluemke DA et al (2008) Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the american heart association committee on cardiovascular imaging and intervention of the council on cardiovascular radiology and intervention, and the councils on clinical cardiology and cardiovascular disease in the young. Circulation 118(5):586–606PubMedCrossRef
4.
5.
Pennell DJ et al (2004) Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J 25(21):1940–1965PubMedCrossRef
6.
Maron BJ et al (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and Council on Epidemiology and Prevention. Circulation 113(14):1807–1816PubMedCrossRef
7.
Elliott P et al (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29(2):270–276PubMedCrossRef
8.
Selvanayagam JB et al (2007) Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 50(22):2101–2110PubMedCrossRef
9.
Vanden Driesen RI, Slaughter RE, Strugnell WE (2006) MR findings in cardiac amyloidosis. AJR Am J Roentgenol 186(6):1682–1685PubMedCrossRef
10.
Krombach GA et al (2007) Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects. J Magn Reson Imaging 25(6):1283–1287PubMedCrossRef
11.
Rathi VK et al (2008) Routine evaluation of left ventricular diastolic function by cardiovascular magnetic resonance: a practical approach. J Cardiovasc Magn Reson 10(1):36PubMedPubMedCentralCrossRef
12.
Vogelsberg H et al (2008) Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 51(10):1022–1030PubMedCrossRef
13.
Syed IS et al (2010) Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 3(2):155–164PubMedCrossRef
14.
Fattori R et al (1998) Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy. Am Heart J 136(5):824–830PubMedCrossRef
15.
16.
Durr A et al (1996) Clinical and genetic abnormalities in patients with Friedreich’s ataxia. N Engl J Med 335(16):1169–1175PubMedCrossRef
17.
Harding AE (1981) Friedreich’s ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104(3):589–620PubMedCrossRef
18.
Isnard R et al (1997) Correlation between left ventricular hypertrophy and GAA trinucleotide repeat length in Friedreich’s ataxia. Circulation 95(9):2247–2249PubMedCrossRef
19.
Rajagopalan B et al (2010) Analysis of the factors influencing the cardiac phenotype in Friedreich’s ataxia. Mov Disord 25(7):846–852PubMedCrossRef
20.
Meyer C et al (2007) Cardiomyopathy in Friedreich’s ataxia-assessment by cardiac MRI. Mov Disord 22(11):1615–1622PubMedCrossRef
21.
22.
Zenker M (2009) Genetic and pathogenetic aspects of Noonan syndrome and related disorders. Horm Res 72(Suppl 2):57–63PubMedCrossRef
23.
Zenker M et al (2007) SOS1 is the second most common Noonan gene but plays no major role in cardio-facio-cutaneous syndrome. J Med Genet 44(10):651–656PubMedPubMedCentralCrossRef
24.
25.
26.
27.
Marino B et al (1999) Congenital heart diseases in children with Noonan syndrome: an expanded cardiac spectrum with high prevalence of atrioventricular canal. J Pediatr 135(6):703–706PubMedCrossRef
28.
Hudsmith LE et al (2006) Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations. Int J Cardiovasc Imaging 22(3–4):493–495PubMedCrossRef
29.
Danon MJ et al (1981) Lysosomal glycogen storage disease with normal acid maltase. Neurology 31(1):51–57PubMedCrossRef
30.
Sugie K et al (2002) Clinicopathological features of genetically confirmed Danon disease. Neurology 58(12):1773–1778PubMedCrossRef
31.
Yang Z et al (2005) Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children. Circulation 112(11):1612–1617PubMedCrossRef
32.
van der Kooi AJ et al (2008) Extension of the clinical spectrum of Danon disease. Neurology 70(16):1358–1359PubMedCrossRef
33.
34.
35.
Ntusi NB, Mayosi BM (2009) Aetiology and risk factors of peripartum cardiomyopathy: a systematic review. Int J Cardiol 131(2):168–179PubMedCrossRef
36.
Kawano H et al (2008) Magnetic resonance imaging in a patient with peripartum cardiomyopathy. Intern Med 47(2):97–102PubMedCrossRef
37.
Caballero-Borrego J et al (2008) Evidence of gadolinium late-enhancement on cardiac magnetic resonance imaging in a patient with peripartum cardiomyopathy. Rev Esp Cardiol 61(2):219–220PubMedCrossRef
38.
Leurent G et al (2009) Contribution of cardiac MRI in the comprehension of peripartum cardiomyopathy pathogenesis. Int J Cardiol 132(3):e91–e93PubMedCrossRef
39.
Mouquet F et al (2008) Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging. Eur Radiol 18(12):2765–2769PubMedCrossRef
40.
Marmursztejn J et al (2009) Delayed-enhanced cardiac magnetic resonance imaging features in peripartum cardiomyopathy. Int J Cardiol 137(3):e63–e64PubMedCrossRef
41.
Baruteau AE et al. (2009) Peripartum cardiomyopathy in the era of cardiac magnetic resonance imaging: first results and perspectives. Int J Cardiol Jan 24. [Epub ahead of print]
42.
43.
Nigro G et al (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26(3):271–277PubMedCrossRef
44.
Yilmaz A et al (2008) Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. J Cardiovasc Magn Reson 10(1):50PubMedPubMedCentralCrossRef
45.
Silva MC et al (2007) Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 49(18):1874–1879PubMedCrossRef
46.
Pereira SR et al (2007) Association between a new 3q;5q chromosomal translocation and dystrophy of human retinal pigment epithelium. Genet Mol Res 6(4):1085–1090PubMed
47.
Nigro G et al (1995) Evaluation of the cardiomyopathy in Becker muscular dystrophy. Muscle Nerve 18(3):283–291PubMedCrossRef
48.
49.
Leikin JB, Klein L (2000) Ephedra causes myocarditis. J Toxicol Clin Toxicol 38(3):353–354PubMed
50.
Kurt TL (2000) Hypersensitivity myocarditis with ephedra use. J Toxicol Clin Toxicol 38(3):351PubMed
51.
Zaacks SM et al (1999) Hypersensitivity myocarditis associated with ephedra use. J Toxicol Clin Toxicol 37(4):485–489PubMedCrossRef
52.
Naik SD, Freudenberger RS (2004) Ephedra-associated cardiomyopathy. Ann Pharmacother 38(3):400–403PubMedCrossRef
53.
Jacobs LJ (1989) Reversible dilated cardiomyopathy induced by methamphetamine. Clin Cardiol 12(12):725–727PubMedCrossRef
54.
Srikanth S, Barua R, Ambrose J (2008) Methamphetamine-associated acute left ventricular dysfunction: a variant of stress-induced cardiomyopathy. Cardiology 109(3):188–192PubMedCrossRef
55.
Lopez JE et al (2009) Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance. J Cardiovasc Magn Reson 11(1):46PubMedPubMedCentralCrossRef
56.
Wood DM et al. (2010) Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol 6(3):327–330
57.
Kmietowicz Z (2010) Home secretary bans mephedrone after taking advice from depleted council. BMJ 340:c1784PubMedCrossRef
58.
LeRoy EC et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202–205PubMed
59.
Takehara K, Soma Y, Ishibashi Y (1991) Early detection of scleroderma spectrum disorders in patients with Raynaud’s phenomenon. Dermatologica 183(3):164–168PubMedCrossRef
60.
Poanta L et al (2009) Systolic and diastolic function in patients with systemic sclerosis. Eur J Intern Med 20(4):378–382PubMedCrossRef
61.
Kahan A, Allanore Y (2006) Primary myocardial involvement in systemic sclerosis. Rheumatology (Oxford) 45(Suppl 4):iv14–iv17
62.
Tzelepis GE et al (2007) Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum 56(11):3827–3836PubMedCrossRef
63.
Weller PF, Bubley GJ (1994) The idiopathic hypereosinophilic syndrome. Blood 83(10):2759–2779PubMed
64.
Bishop GG, Bergin JD, Kramer CM (2001) Hypereosinophilic syndrome and restrictive cardiomyopathy due to apical thrombi. Circulation 104(2):E3–E4PubMedCrossRef
65.
Salanitri GC (2005) Endomyocardial fibrosis and intracardiac thrombus occurring in idiopathic hypereosinophilic syndrome. AJR Am J Roentgenol 184(5):1432–1433PubMedCrossRef
66.
Goo HW, Han NJ, Lim TH (2001) Endomyocardial fibrosis mimicking right ventricular tumor. AJR Am J Roentgenol 177(1):205–206PubMedCrossRef
67.
Syed IS et al (2008) Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease. Int J Cardiol 126(3):e50–e52PubMedCrossRef
68.
Lam KY, Dickens P, Chan AC (1993) Tumors of the heart. A 20-year experience with a review of 12, 485 consecutive autopsies. Arch Pathol Lab Med 117(10):1027–1031PubMed
69.
Mukai K et al (1988) The incidence of secondary tumors of the heart and pericardium: a 10-year study. Jpn J Clin Oncol 18(3):195–201PubMed
70.
71.
Choe DH et al (1998) Obliteration of the pulmonary vein in lung cancer: significance in assessing local extent with CT. J Comput Assist Tomogr 22(4):587–591PubMedCrossRef
72.
Roberts WC, Glancy DL, DeVita VT Jr (1968) Heart in malignant lymphoma (Hodgkin’s disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides). A study of 196 autopsy cases. Am J Cardiol 22(1):85–107PubMedCrossRef
73.
Chiles C et al (2001) Metastatic involvement of the heart and pericardium: CT and MR imaging. Radiographics 21(2):439–449PubMedCrossRef
74.
75.
Fujita N, Caputo GR, Higgins CB (1994) Diagnosis and characterization of intracardiac masses by magnetic resonance imaging. Am J Card Imaging 8(1):69–80PubMed
76.
77.
Deetjen A et al (2006) Cardiac metastasis of a renal cell adenocarcinoma investigated by cardiac magnetic resonance imaging. Clin Res Cardiol 95(9):492–495PubMedCrossRef
78.
Oechslin EN et al (2000) Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 36(2):493–500PubMedCrossRef
79.
Chin TK et al (1990) Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation 82(2):507–513PubMedCrossRef
80.
Sen-Chowdhry S, McKenna WJ (2008) Left ventricular noncompaction and cardiomyopathy: cause, contributor, or epiphenomenon? Curr Opin Cardiol 23(3):171–175PubMedCrossRef
81.
Petersen SE et al (2005) Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 46(1):101–105PubMedCrossRef
82.
Jenni R et al (2001) Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 86(6):666–671PubMedPubMedCentralCrossRef
83.
Burke A et al (2005) Left ventricular noncompaction: a pathological study of 14 cases. Hum Pathol 36(4):403–411PubMedCrossRef
84.
Borges AC, Kivelitz D, Baumann G (2003) Isolated left ventricular non-compaction: cardiomyopathy with homogeneous transmural and heterogeneous segmental perfusion. Heart 89(8):e21PubMedPubMedCentralCrossRef
85.
Finsterer J, Stollberger C, Kopsa W (2005) Multidisciplinary diagnostic approach for left ventricular hypertrabeculation/noncompaction. Yonsei Med J 46(2):309–310, author reply 310-2PubMedPubMedCentralCrossRef
86.
Lilje C et al (2006) Complications of non-compaction of the left ventricular myocardium in a paediatric population: a prospective study. Eur Heart J 27(15):1855–1860PubMedCrossRef
87.
Bagur RH et al (2008) Images in cardiovascular medicine. Ebstein anomaly associated with left ventricular noncompaction. Circulation 118(16):e662–e664PubMedCrossRef
88.
Pignatelli RH et al (2003) Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy. Circulation 108(21):2672–2678PubMedCrossRef
89.
Dursun M et al (2010) MR imaging features of ventricular noncompaction: emphasis on distribution and pattern of fibrosis. Eur J Radiol 74(1):147–151PubMedCrossRef
90.
Kohli SK et al (2008) Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J 29(1):89–95PubMedCrossRef
91.
Cerqueira MD et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105(4):539–542PubMedCrossRef
92.
Dote K et al (1991) Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases. J Cardiol 21(2):203–214PubMed
93.
Eitel I et al (2010) Inflammation in takotsubo cardiomyopathy: insights from cardiovascular magnetic resonance imaging. Eur Radiol 20(2):422–431PubMedCrossRef
94.
Wittstein IS et al (2005) Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352(6):539–548PubMedCrossRef
95.
Abraham J et al (2009) Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. J Am Coll Cardiol 53(15):1320–1325PubMedCrossRef
96.
Nef HM et al (2007) Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J 28(20):2456–2464PubMedCrossRef
97.
Sharkey SW et al (2010) Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol 55(4):333–341PubMedCrossRef
98.
Eitel I et al (2008) Differential diagnosis of suspected apical ballooning syndrome using contrast-enhanced magnetic resonance imaging. Eur Heart J 29(21):2651–2659PubMedCrossRef
99.
Rolf A et al (2009) Immunohistological basis of the late gadolinium enhancement phenomenon in tako-tsubo cardiomyopathy. Eur Heart J 30(13):1635–1642PubMedCrossRef
Metadata
Title
Uncharted waters: rare and unclassified cardiomyopathies characterized on cardiac magnetic resonance imaging
Authors
Ailbhe C. O’Neill
Shaunagh McDermott
Carole A. Ridge
Kenneth McDonald
David Keane
Jonathan D. Dodd
Publication date
01-11-2010
Publisher
Springer Berlin Heidelberg
Published in
Insights into Imaging / Issue 5-6/2010
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1007/s13244-010-0045-4

Other articles of this Issue 5-6/2010

Insights into Imaging 5-6/2010 Go to the issue

Review

Technical aspects of CT imaging of the spine

Review

Imaging of endometrial and cervical cancer

Review

Imaging for suspected pulmonary embolism in pregnancy—what about the fetal dose? A comprehensive review of the literature

Pictorial Review

Imaging of pancreas transplantation and its complications

Review

Imaging with non-FDG PET tracers: outlook for current clinical applications

Pictorial Review

Pancreatic transplantation: surgical technique, normal radiological appearances and complications